|
|
4088 Commercial Avenue
Northbrook, IL 60062 USA
phone:847.400.9000
fax:847.400.9199
|
|
| Symbol |
NSPH |
| Exchange |
Nasdaq |
| Founded |
2000 |
| Employees |
|
|
|
| www.nanosphere-inc.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Nanosphere is a nanotechnology-based life sciences company. |
|
| Management |
| William Moffitt, President and Chief Executive Officer; William Cork, Vice President of Research and Development and Chief Technology Officer; Michael McGarrity, Vice President of Sales and Marketing and Chief Marketing Officer; Roger Moody, Vice President of Finance, Treasurer and Chief Financial Officer; Greg Shipp, Chief Medical Officer; Bill Athenson, Vice President of International Sales and Marketing; Winton Gibbons, Senior Vice President of Business Development; Thomas F. Holzman, Vice President of Research, Protein Sciences; Greg Pletta, Vice President of Intellectual Property; |
| |
|
|
|
|
|
|
|
| Keywords |
| life sciences, nanotechnology, nanoparticle probes, infectious disease, diagnostics |
|
|
|
| Description |
|
Nanosphere, Inc. is a nanotechnology-based life sciences company. Our mission is to create new standards in discovery, medical care, and public safety through the application of proprietary nanotechnology. |
|
| Products / Services |
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, for direct genomic and ultra-sensitive protein detection. This easy-to-use and cost-effective platform enables simple, low-cost and highly sensitive genomic and protein testing on a single platform.
|
|
| Technology / Differentiation |
| Nanosphere is harnessing the unique properties of matter at the nano-scale in order to commercialize the proprietary chemistry (nanoparticle probes, bio-barcode' technology and automated instruments) that is the foundation of its platform. |
|
| Market / Customers |
Nanosphere's technology enables simplicity of molecular testing that will expand its use even to the point of care.
The worldwide market opportunity has an equally impressive potential.
Target areas include genetics, infectious diseases, cancer, pharmacogenomics, blood screening, neurodegenerative and cardiovascular diseases.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
